You are here

  • Home
  • Archive
  • Volume 77, Issue 3
  • Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study

 

Online download statistics by month:

Online download statistics by month: November 2017 to March 2024

AbstractFullPdf
Nov 20171082199161
Dec 2017840162126
Jan 2018601138118
Feb 20181118200164
Mar 20181038267171
Apr 201854912887
May 2018111612875
Jun 20185087939
Jul 20182836539
Aug 20183838549
Sep 20182936548
Oct 20185997753
Nov 20183666143
Dec 20182973621
Jan 20194186546
Feb 20193255353
Mar 20194825039
Apr 20192706148
May 20193136051
Jun 20193035933
Jul 20192765630
Aug 20192214729
Sep 20193386838
Oct 20193417035
Nov 20192535822
Dec 20192254624
Jan 20202904016
Feb 20202603725
Mar 20202793524
Apr 20202513322
May 20201632521
Jun 20201932919
Jul 20201783220
Aug 20201712621
Sep 20201542316
Oct 20201652316
Nov 20201713215
Dec 20201742817
Jan 20211691714
Feb 20211421220
Mar 20212002017
Apr 2021132105
May 2021741713
Jun 2021392216
Jul 202132167
Aug 2021281512
Sep 202139219
Oct 20212034313
Nov 20211743517
Dec 20211672111
Jan 2022139168
Feb 2022140157
Mar 20222092115
Apr 2022257135
May 20221882312
Jun 2022181207
Jul 2022192248
Aug 20221785111
Sep 2022238477
Oct 20222423111
Nov 2022207359
Dec 2022165246
Jan 2023191326
Feb 2023324306
Mar 20232412710
Apr 20231752612
May 2023337218
Jun 20231582111
Jul 2023148174
Aug 20232354015
Sep 20231593113
Oct 2023116135
Nov 2023186306
Dec 20233164314
Jan 2024186376
Feb 20243563723
Mar 2024303219
Total2245337412282